Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Moderate COVID-19 Pneumonia, Severe COVID-19 Pneumonia”

Showing 20 of 0 results

Very early researchWithdrawnNCT04323631
What this trial is testing

Hydroxychloroquine for the Treatment of Patients With Mild to Moderate COVID-19 to Prevent Progression to Severe Infection or Death

Who this might be right for
COVID-19
Rambam Health Care Campus
Testing effectiveness (Phase 2)Ended earlyNCT05451654
What this trial is testing

NanoMn®_COVID-19 A Prospective, Multicenter, Randomized, Placebo-controlled, Parallel-group, Double-blind Trial to Evaluate the Clinical Efficacy of NanoManganese® on Top of Standard of Care, in Adult Patients With Moderate to Severe Coronavirus Disease 2019 (COVID-19)

Who this might be right for
COVID-19 Pandemic
Medesis Pharma SA 7
Testing effectiveness (Phase 2)Study completedNCT04606069
What this trial is testing

Treat COVID-19 Patients With Regadenoson

Who this might be right for
COVID-19Lung Inflammation
University of Maryland, Baltimore 5
Testing effectiveness (Phase 2)Study completedNCT04392414
What this trial is testing

Hyperimmune Convalescent Plasma in Moderate and Severe COVID-19 Disease

Who this might be right for
COVID-19
Federal Research Clinical Center of Federal Medical & Biological Agency, Russia 60
Testing effectiveness (Phase 2)Ended earlyNCT04679350
What this trial is testing

Efficacy and Safety of hzVSFv13 in Patients With COVID-19 Pneumonia

Who this might be right for
COVID-19
ImmuneMed, Inc. 1
Large-scale testing (Phase 3)WithdrawnNCT05157243
What this trial is testing

Trial to Evaluate Nitazoxanide for Treatment of Mild or Moderate COVID-19 in Subjects at High Risk of Severe Illness

Who this might be right for
COVID-19
Romark Laboratories L.C.
Not applicableStudy completedNCT04664010
What this trial is testing

Efficacy and Safety of High-dose Vitamin C Combined With Chinese Medicine Against Coronavirus Pneumonia (COVID-19)

Who this might be right for
COVID-19
Xi'an International Medical Center Hospital 30
Not applicableStudy completedNCT04667923
What this trial is testing

Noninvasive Ventilation in Moderate-to-severe COVID-19-associated Acute Respiratory Distress-syndrome

Who this might be right for
Covid19ARDS
I.M. Sechenov First Moscow State Medical University 80
Early research (Phase 1)Ended earlyNCT05386472
What this trial is testing

Learn About the Study Medicine (Nirmatrelvir Plus Ritonavir) in Pregnant Women With COVID-19

Who this might be right for
COVID-19
Pfizer 25
Large-scale testing (Phase 3)UnknownNCT04873414
What this trial is testing

Convalescent Plasma as Adjunct Therapy for COVID-19

Who this might be right for
COVID-19
National Institute of Health Research and Development, Ministry of Health Republic of Indonesia 364
Not applicableStudy completedNCT05343728
What this trial is testing

Thromboelastographic Methods in Deciding Therapy on Moderate to Severe COVID-19 Patients

Who this might be right for
COVID-19
Universitas Indonesia 100
Testing effectiveness (Phase 2)Ended earlyNCT04498377
What this trial is testing

Study of F-652 (IL-22:IgG2 Fusion Protein) in Patients With Moderate to Severe COVID-19

Who this might be right for
Covid19
EVIVE Biotechnology 1
Large-scale testing (Phase 3)Study completedNCT04732949
What this trial is testing

Study to Assess Efficacy and Safety of Inhaled Interferon-β Therapy for COVID-19

Who this might be right for
Severe Acute Respiratory Syndrome Coronavirus 2COVID-19
Synairgen Research Ltd. 623
Large-scale testing (Phase 3)Study completedNCT04501783
What this trial is testing

Study of Efficacy and Safety of TL-FVP-t vs. SOC in Patients With Mild to Moderate COVID-19

Who this might be right for
COVID-19
R-Pharm 168
Early research (Phase 1)Study completedNCT05151614
What this trial is testing

Adjuvant Use Of Colchicine With The Standard Therapy In Moderate And Severe Corona Virus Disease-19 Infection

Who this might be right for
COVID-19 Pandemic
University of Baghdad 160
Not applicableStudy completedNCT07072793
What this trial is testing

A US Study to Look at Loss of Work and Healthcare Costs for People Affected With Mild-to-moderate COVID 19 Who Have High Chances of the Disease Becoming Severe

Who this might be right for
COVID-19 (Coronavirus Disease 2019)
Pfizer 131,005
Not applicableStudy completedNCT04657445
What this trial is testing

EFFECT OF COVID-19 DISEASE IN SMELL AND TASTE OF PATIENTS WITH MILD, MODERATE OR SEVERE SYMPTOMATOLOGY

Who this might be right for
Olfactory and Taste Dysfunction in SARS-CoV2 Infection
University Hospital, Ioannina 100
Very early researchTemporarily pausedNCT04329572
What this trial is testing

Efficacy and Safety of Hydroxychloroquine and Azithromycin for Patients With Moderate to Severe COVID-19

Who this might be right for
COVID-19
Azidus Brasil 400
Large-scale testing (Phase 3)Ended earlyNCT04344444
What this trial is testing

Treatment in Patients With Suspected or Confirmed COVID-19 With Early Moderate or Severe Disease

Who this might be right for
COVID-19
LCMC Health 22
Not applicableWithdrawnNCT04466657
What this trial is testing

Antioxidant Therapy for COVID-19 Study

Who this might be right for
Covid-19
Obafemi Awolowo University
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation